MENU
MURA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mural Oncology (MURA) Ownership - Who owns Mural Oncology?
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more
Profile
Industry
N/A
Address
10 Earlsfort Terrace
Phone
+353 19058020
Employees
117
Web
https://www.muraloncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.36M
P/E Ratio
N/A
Total Cash
144.39M
Projected Growth
N/A
Total Debt
8.02M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.38
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MURA
Capitalization
21.4M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
144M
Total Cash/Share
8.38
Total Debt
8.02M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
141M
P/B Ratio
0.15
Cash Flow
N/A
Earnings
-7.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
171K
Current Ratio
5.84
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-134.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-54.55
Shares Held By Institutions
29.1M
Shares Outstanding - Current
17.2M
Total Liabilities
28.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-61.801
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
10 Earlsfort Terrace
Phone
+353 19058020
Employees
117
Web
https://www.muraloncology.com